hotspot -WSS

hotspot

author：focus 2025-10-01 04:12:33 - browse：8

Are venture capitalists OK? Are bolt-ons good for business? And when is it safe to say someone overpaid?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. We discuss how biotech’s downturn has made life difficult not just for startups but also the VCs they rely on for much-needed funding. We also take a look at Gilead Sciences’ struggle to turn itself into an oncology company and the latest biotech to get bought out by a major pharma firm.

For more on what we cover, here’s more on Gilead; here’s the news on Inhibrx; here’s the latest on biotech venture capital; here’s where you can find episodes of Color Code; here’s where you can subscribe to the First Opinion Podcast; and here’s where you can subscribe to our biotech newsletter, The Readout.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum
Next article： The thinking behind the controversial eating disorder chatbot Tessa

knowledge

focus

WSS

We're not in Australia anymore: Kansas cops jump into action to save kangaroo

New report analyzes digital physical therapy solutions' effectiveness

Cancer thrives by mutating. But sometimes, a mutation leaves it vulnerable

Statins may not be needed by millions of people, study suggests

We're not in Australia anymore: Kansas cops jump into action to save kangaroo

Statins may not be needed by millions of people, study suggests

Wikipedia

hotspot

hotspot

Affirmative action in medical school literally saved lives

Moderna says combo Covid

23andMe had bad news about my health. I wish a person had delivered it

Science's Marcia McNutt, trailblazer for women, encounters sexism scandal

23andMe had bad news about my health. I wish a person had delivered it

Can medical device makers keep up in the race to treat obesity?

23andMe had bad news about my health. I wish a person had delivered it

Cancer thrives by mutating. But sometimes, a mutation leaves it vulnerable

DIEP, the 'gold standard' of breast reconstruction, is under threat

Curing rare childhood diseases will falter unless Congress steps up

knowledge

Heat wave can put hearts into ‘oxygen debt,' lab experiment shows

How faith leaders like me can help address America's obesity epidemic

Heat wave can put hearts into ‘oxygen debt,' lab experiment shows

Cigna wins case to block Amy Bricker's move to CVS

Millions may soon lose Medicaid when they don't have to

Study: Why relieving medical debt did not improve financial outcomes

knowledge

focus

hotspot

explore